07/01/2025
3:05 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
5:11 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2025
4:01 PM | Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:39 PM | Castle Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
7:19 PM | BlackRock, Inc. (Filed by)
Castle Biosciences (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
2:34 PM | Castle Biosciences (Subject)
Portolan Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
04/10/2025
3:07 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
10:43 AM | Castle Biosciences (Filer)
| Form DEF 14A | |
04/09/2025
10:45 AM | Castle Biosciences (Filer)
| Form DEFA14A | |
04/09/2025
10:47 AM | Castle Biosciences (Filer)
| Form ARS | |
04/08/2025
3:56 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for CSTL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Castle Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
03/25/2025
6:06 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 4/A | |
03/12/2025
3:30 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 4/A | |
03/06/2025
3:10 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:28 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:10 PM | Castle Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
3:13 PM | Castle Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2025
3:23 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:25 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
8:33 PM | Castle Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/15/2025
3:57 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
5:58 AM | Castle Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
5:19 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:17 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:18 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:39 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:00 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:55 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:09 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:28 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:14 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
5:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
5:44 PM | Castle Biosciences (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:32 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:33 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:34 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:49 PM | Castle Biosciences (Subject)
Juvenal Tobin W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
3:34 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:22 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad) Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents.
With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside. Get the name of Buffett’s likely gold target here |
10/09/2024
3:30 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:48 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:33 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:23 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:33 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:15 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
4:18 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:06 PM | Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:07 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:11 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:17 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
5:13 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:14 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:15 PM | Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:16 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:17 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:37 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024
2:13 PM | Castle Biosciences (Subject)
Stokes Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
5:43 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4/A | |
07/16/2024
3:49 PM | Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:51 PM | Caple Kim (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
